163 related articles for article (PubMed ID: 37881790)
1. Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L.
Fernández-de-la-Pradilla A; Royo S; Schirmeister T; Barthels F; Świderek K; González FV; Moliner V
ACS Catal; 2023 Oct; 13(20):13354-13368. PubMed ID: 37881790
[TBL] [Abstract][Full Text] [Related]
2. Impact of Warhead Modulations on the Covalent Inhibition of SARS-CoV-2 M
Martí S; Arafet K; Lodola A; Mulholland AJ; Świderek K; Moliner V
ACS Catal; 2022 Jan; 12(1):698-708. PubMed ID: 35036042
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Recognition Part of Dipeptidyl Nitroalkene Compounds on the Inhibition Mechanism of Cysteine Proteases Cruzain and Cathepsin L.
Arafet K; Royo S; Schirmeister T; Barthels F; González FV; Moliner V
ACS Catal; 2023 May; 13(9):6289-6300. PubMed ID: 37180968
[TBL] [Abstract][Full Text] [Related]
4. Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis.
Welss T; Sun J; Irving JA; Blum R; Smith AI; Whisstock JC; Pike RN; von Mikecz A; Ruzicka T; Bird PI; Abts HF
Biochemistry; 2003 Jun; 42(24):7381-9. PubMed ID: 12809493
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of SARS-CoV-2 M
Arafet K; Serrano-Aparicio N; Lodola A; Mulholland AJ; González FV; Świderek K; Moliner V
Chem Sci; 2020 Nov; 12(4):1433-1444. PubMed ID: 34163906
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Reversibility for Covalent Cysteine Protease Inhibitors Using Quantum Mechanics/Molecular Mechanics Free Energy Surfaces.
Dos Santos AM; Oliveira ARS; da Costa CHS; Kenny PW; Montanari CA; Varela JJG; Lameira J
J Chem Inf Model; 2022 Sep; 62(17):4083-4094. PubMed ID: 36044342
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
8. A microscopic description of SARS-CoV-2 main protease inhibition with Michael acceptors. Strategies for improving inhibitor design.
Ramos-Guzmán CA; Ruiz-Pernía JJ; Tuñón I
Chem Sci; 2021 Jan; 12(10):3489-3496. PubMed ID: 34163622
[TBL] [Abstract][Full Text] [Related]
9. Development of peptidomimetics with a vinyl sulfone warhead as irreversible falcipain-2 inhibitors.
Ettari R; Nizi E; Di Francesco ME; Dude MA; Pradel G; Vicík R; Schirmeister T; Micale N; Grasso S; Zappalà M
J Med Chem; 2008 Feb; 51(4):988-96. PubMed ID: 18232656
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of warheads for design of cysteine protease inhibitors.
Silva DG; Ribeiro JFR; De Vita D; Cianni L; Franco CH; Freitas-Junior LH; Moraes CB; Rocha JR; Burtoloso ACB; Kenny PW; Leitão A; Montanari CA
Bioorg Med Chem Lett; 2017 Nov; 27(22):5031-5035. PubMed ID: 29054358
[TBL] [Abstract][Full Text] [Related]
11. In silico identification of irreversible cathepsin B inhibitors as anti- cancer agents: virtual screening, covalent docking analysis and molecular dynamics simulations.
Sbongile M; Soliman ME
Comb Chem High Throughput Screen; 2015; 18(4):399-410. PubMed ID: 25747438
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Cruzain Cysteine Protease Reversible and Irreversible Covalent Inhibition Mechanism.
Silva JRA; Cianni L; Araujo D; Batista PHJ; de Vita D; Rosini F; Leitão A; Lameira J; Montanari CA
J Chem Inf Model; 2020 Mar; 60(3):1666-1677. PubMed ID: 32126170
[TBL] [Abstract][Full Text] [Related]
13. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
Falgueyret JP; Oballa RM; Okamoto O; Wesolowski G; Aubin Y; Rydzewski RM; Prasit P; Riendeau D; Rodan SB; Percival MD
J Med Chem; 2001 Jan; 44(1):94-104. PubMed ID: 11141092
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.
Flury P; Breidenbach J; Krüger N; Voget R; Schäkel L; Si Y; Krasniqi V; Calistri S; Olfert M; Sylvester K; Rocha C; Ditzinger R; Rasch A; Pöhlmann S; Kronenberger T; Poso A; Rox K; Laufer SA; Müller CE; Gütschow M; Pillaiyar T
ACS Pharmacol Transl Sci; 2024 Feb; 7(2):493-514. PubMed ID: 38357286
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and kinetic evaluation of ethyl acrylate and vinyl sulfone derived inhibitors for human cysteine cathepsins.
Breuer C; Lemke C; Schmitz J; Bartz U; Gütschow M
Bioorg Med Chem Lett; 2018 Jun; 28(11):2008-2012. PubMed ID: 29748052
[TBL] [Abstract][Full Text] [Related]
16. A road map for prioritizing warheads for cysteine targeting covalent inhibitors.
Ábrányi-Balogh P; Petri L; Imre T; Szijj P; Scarpino A; Hrast M; Mitrović A; Fonovič UP; Németh K; Barreteau H; Roper DI; Horváti K; Ferenczy GG; Kos J; Ilaš J; Gobec S; Keserű GM
Eur J Med Chem; 2018 Dec; 160():94-107. PubMed ID: 30321804
[TBL] [Abstract][Full Text] [Related]
17. MD-Based Assessment of Covalent Inhibitors in Noncovalent Association Complexes: Learning from Cathepsin K as a Test Case.
Endres E; Yuan Chen N; Sotriffer C
J Chem Inf Model; 2023 May; 63(10):3186-3197. PubMed ID: 37165835
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
Beers C; Honey K; Fink S; Forbush K; Rudensky A
J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
[TBL] [Abstract][Full Text] [Related]
19. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
20. Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases.
Brogi S; Ibba R; Rossi S; Butini S; Calderone V; Gemma S; Campiani G
Molecules; 2022 Apr; 27(8):. PubMed ID: 35458759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
